Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
MYC, as a well-known oncogene, plays essential roles in promoting tumor occurrence, development, invasion and metastasis in many kinds of solid tumors and hematologic neoplasms. In tumors, the low expression and the short half-life of Myc are reversed, cause tumorigenesis. And proteins that directly...
Saved in:
Main Authors: | Yihui Zhou (Author), Xiaomeng Gao (Author), Meng Yuan (Author), Bo Yang (Author), Qiaojun He (Author), Ji Cao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
by: Yihui Zhou, et al.
Published: (2021) -
The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
by: Xuankun Chen, et al.
Published: (2022) -
Bafetinib Suppresses the Transcription of PD-L1 Through c-Myc in Lung Cancer
by: Xi Chen, et al.
Published: (2022) -
WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
by: Xiaomeng Gao, et al.
Published: (2022) -
Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
by: Yi-Zheng Fang, et al.
Published: (2023)